Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Identify index funds with top risk-adjusted returns to guide smarter allocations. Learn criteria for selecting high-efficiency funds.
28,465 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Netflix trades near its 52-week low as operating strength clashes with subscriber-growth concerns. A stronger FY26 ca...
Micron stock retreats after a spring rally, renewing the debate over whether the memory chip maker has peaked. Analys...
A collaboration blends Star Wars icons with NFL teams, sparking fan excitement and new budgeting needs. This guide br...
A retiree watched a $1.2m portfolio fall $187,000 in three weeks amid volatile markets. Experts say a bond sleeve cou...
When anthony anderson finally gets a fresh Wayans reunion, it isn’t just fan excitement—it’s a real-world case study ...
A federal watchdog uncovered millions in preopening costs at a Texas detention facility, raising questions about budg...
South Korea’s memory-chip giant SK Hynix plans a Nasdaq debut with a roughly $29 billion offer, aiming to test if AI-...
A misdirected public-comment inbox is stirring confusion over the SEC's plan to scrap quarterly reporting. Officials ...
Galaxy Digital announced up to $5 million in funding to accelerate Bitcoin's transition to quantum-resistant security...
Google’s Gemini AI released a bold Solana forecast, pairing a performance upgrade roadmap with a price trajectory tha...
Investors are watching Kevin Warsh as a potential Fed chair, weighing policy shifts and market risks as leaders debat...